Loading organizations...
Allomer Capital Group is a Santa Monica, California-based private investment firm that provides flexible, long-term capital to companies operating across the healthcare, media, technology, and technology-enabled services sectors. The firm operates with fewer than 25 employees and generates under $5 million in annual revenue, while its leadership has historically directed over $1.2 billion in capital across more than 25 corporate investments. Structured as a strategic partnership with Moore Strategic Ventures, the primary investment vehicle for Louis M. Bacon, the firm acquires equity stakes in middle-market businesses to fund corporate expansion. The organization frequently collaborates with leading industry executives to execute targeted buyouts, notably partnering with former Walgreens CEO Greg Wasson and Capstone Consultants to acquire the pharmacy automation provider Innovation Associates. Allomer Capital Group was officially founded in 2017 by managing partner Steve Chang.
Allomer Capital Group is a private investment firm established in 2016, with its operations based out of Los Angeles, California. The firm positions itself within the broader venture capital and private equity landscape, specializing in providing flexible capital solutions. Its primary objective is to support companies that are in their growth and expansion stages, offering the financial resources necessary for their continued development and market penetration.
The firm's investment philosophy is centered on identifying promising businesses across various sectors that exhibit strong potential for scaling and innovation. Allomer Capital Group's approach involves a thorough evaluation of market opportunities and management teams, aiming to deploy capital in a manner that maximizes growth trajectories for its portfolio entities. This strategic deployment of flexible capital is designed to meet the evolving needs of companies as they navigate their expansion phases.
As a participant in the regulated financial industry, Allomer Capital Group is registered as an Exempt Reporting Adviser. This status signifies its compliance with specific regulatory requirements and its operational transparency within the investment advisory framework, as overseen by relevant authorities. This registration ensures that the firm operates under established guidelines for investment advisers.
Allomer Capital Group contributes to the broader venture ecosystem by acting as a source of capital for companies seeking to expand their operations, develop new products, or enter new markets. Its role as a growth/expansion firm underscores its commitment to fostering innovation and economic development through strategic investments. The firm aims to partner with companies that are ready to scale, providing not just capital but also a strategic perspective to aid in their long-term success.
Allomer Capital Group has 1 tracked investment across 1 company. The latest tracked deal is Series B in TRUCE Software in February 2026.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 12, 2026 | TRUCE Software | Series B | Yttrium | NEW Amsterdam Growth Capital |